Eureka Therapeutics, Inc., a clinical-stage biotechnology company advancing next-generation T-cell therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.
Trump’s remarks, delivered over the past two days, have set the tone for a wider escalation, as governments from Mexico to Greenland, as well as Cuba and Iran, have reacted with alarm, rejection or ...
Fast Lane Only on MSN
When the 2019 Hyundai Veloster N changed brand perception
The 2019 Hyundai Veloster N arrived as a compact hatchback with outsized expectations riding on its shoulders. Hyundai had ...
New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...
Limited 2026 Elantra N TCR Edition launches in Canada at $50,158 CAD ($36,271 USD) 276 hp, 6-speed manual and race-inspired features like a Carbon Swan Neck Spoiler Alcantara interior, forged wheels ...
Acute graft-versus-host disease (aGVHD) is a life-threatening complication after allogeneic hematopoietic stem cell ...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, is advancing ...
News-Medical.Net on MSN
Study provides a new paradigm for managing transplant‑related immune complications
Acute graft-versus-host disease (aGVHD) is one of the most serious complications after allogeneic hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results